Hemospermia after transrectal ultrasound (TRUS)-guided prostatic biopsy: a prospective study.

Trans-rectal ultrasound (trus) is a safe,cost-effective,radiation free imaging modality for evaluation of prostate. but unfortunately,hemospermia is known to be associated with trus -guided prostate biopsy. this study measured the incidence & risk factors,of hemospermia in patients undergoing trans-rectal ultrasonography (trus). a prospective observational study involving patients undergoing trus for suspected prostate cancer has been conducted at al-hussein and sayed galal,university hospitals. 40patients were included in the study. the results showed that 18 out of 40 patients (45%) undergoing trus-guided prostatic biopsy,who were able to ejaculate,experienced hemospermia,which was associated with some degree of anxiety. the mean duration of hemospermia was 4 (+/- 1.4) weeks. the number of ejaculations before the complete resolution of hemospermia was 6 (+/- 5.6). none of the clinical and pathological factors were significant predictors of the duration of hemospermia.